Kineta, Inc. (OTC Pink: KANT) , a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced today that its ...

Children’s and young adult author Jason Reynolds, 40, was named a fellow for his work capturing the rich inner lives of kids of color and creating powerful moments of human connection in his books.

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, will hold its third-quarter 2024 sales and earnings conference call with institutional ...

Jason Kelce is having a fun retirement — and seemingly turning heads while hanging with fans. The longtime Eagles center was spotted relaxing shirtless on a beach — geotagged in New Jersey ...

Earlier this month, Chelsea released a statement on their website confirming that Jason Gannon had been promoted from his role as chief operating officer to president & chief operating officer.

DAKOTA COUNTY, Neb. (KTIV) - The jury has reached a verdict for Jason Jones. After 10 days of trial, the 12-member jury spent just over seven hours over Wednesday night and Thursday morning to ...

Merck & Co. has picked up options on two Evaxion Biotech vaccine candidates, paying $3.2 million and dangling more than $1 billion in milestones for the chance to pick up preclinical prospects ...

Australia's Jason Day will lead out the International team in its attempt to win this year's Presidents Cup. Day is joined on the team by fellow Australians Adam Scott and Min Woo Lee, who is also ...

One other person who has Kelce's back is his older brother, Jason Kelce. The former Eagles star stood up for his brother during this week's New Heights episode and got emotional while telling him ...

Sept 25 (Reuters) - Merck (MRK.N), opens new tab said on Wednesday a combination of its experimental drug and blockbuster therapy Keytruda failed a late-stage trial testing it in previously ...

Bristol Myers Squibb's (NYSE:BMY) Opdivo (nivolumab) and Merck's (NYSE:MRK) Keytruda (pembrolizumab), two highly popular checkpoint inhibitors used in the treatment of various types of cancer ...